Marvin Carl Gershengorn

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 29, 2024
An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.

Rhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor

|Nov 17, 2021
Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease.

Christine C Krieger, Xiangliang Sui, George J Kahaly

|Jul 27, 2017
De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.

Cintia E Citterio, Balaji Veluswamy, Sarah J Morgan

Pageof 1